P. Aftimos
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
- Radiopharmaceutical Chemistry and Applications
- Medical Imaging Techniques and Applications
- Oncology top 10%
- HER2/EGFR in Cancer Research
- Peptidase Inhibition and Analysis
- Cancer Treatment and Pharmacology
- CAR-T cell therapy research
Papers in
- Oncology 6
- HER2/EGFR in Cancer Research 3
- Cancer Treatment and Pharmacology 3
- Colorectal Cancer Treatments and Studies 1
- Cancer Immunotherapy and Biomarkers 1
-
- Advanced Breast Cancer Therapies 1
- Co-authors
- Ahmad Awada (3 shared papers)Patrick Emonts (1 shared paper)Thomas Guiot (1 shared paper)Zéna Wimana (1 shared paper)Sigrid Stroobants (1 shared paper)Manon Huizing (1 shared paper)J. Tol (1 shared paper)Daniëlle J. Vugts (1 shared paper)
- Journals
- Annals of Oncology (2 papers)Journal of Clinical Oncology (1 paper)ESMO Open (1 paper)Medical Oncology (1 paper)Expert Opinion on Drug Metabolism & Toxicology (1 paper)
- Partner nations
- BelgiumUnited StatesGermany
In The Last Decade
P. Aftimos
6 papers receiving 307 citations
Peers
Comparison fields: 5 of 36
- Radiology, Nuclear Medicine and Imaging 206
- Oncology 200
- Immunology and Allergy 10
- Pulmonary and Respiratory Medicine 49
- Cancer Research 23
Countries citing papers authored by P. Aftimos
This map shows the geographic impact of P. Aftimos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Aftimos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Aftimos more than expected).
Fields of papers citing papers by P. Aftimos
This network shows the impact of papers produced by P. Aftimos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Aftimos. The network helps show where P. Aftimos may publish in the future.
Co-authors
The 25 scholars most cited alongside P. Aftimos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 270 | |
| 2 | 2016 | 22 | |
| 3 | 2022 | 7 | |
| 4 | 2010 | 5 | |
| 5 | 2008 | 4 | |
| 6 | 2022 | 2 |
About P. Aftimos
P. Aftimos is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Infectious Diseases and Organic Chemistry, having authored 6 papers that have together received 310 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (3 papers), Cancer Treatment and Pharmacology (3 papers), Colorectal Cancer Treatments and Studies (1 paper), Cancer Immunotherapy and Biomarkers (1 paper), Radiopharmaceutical Chemistry and Applications (1 paper) and Advanced Breast Cancer Therapies (1 paper). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (206 citations), Oncology (200 citations), Immunology and Allergy (10 citations), Pulmonary and Respiratory Medicine (49 citations) and Cancer Research (23 citations). P. Aftimos has collaborated with scholars based in Belgium, United States and Germany. Frequent co-authors include Ahmad Awada, Patrick Emonts, Thomas Guiot, Zéna Wimana, Sigrid Stroobants, Manon Huizing, J. Tol, Daniëlle J. Vugts, Carolina P. Schröder and Adrienne H. Brouwers. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, ESMO Open, Medical Oncology and Expert Opinion on Drug Metabolism & Toxicology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.